Lupin launches fixed dose triple combo inhaler for COPD in India
The product is an important addition to Lupin’s respiratory portfolio.
· 10/7/2026, 12:18:39 PM· 2 min read

The product is an important addition to Lupin’s respiratory portfolio.
Read original story →Related stories

business
RBI to allow inter-operability among account aggregators; integrate bank deposits with CAS

business
CDK Global appoints Sudhakar Ramakrishna CEO

business
GST Council meets tomorrow, tax experts say reforms must move beyond rates to processes, compliance

business